Vivo Opportunity, LLC

Average Profitability
0.36%
Insider Buys Quantity
1
Insider Buys Sum
$5.5M
Insider Sells Quantity
8
Insider Sells Sum
$103.71M

Insider Activity of Vivo Opportunity, LLC

According to the SEC Form 4 filings, Vivo Opportunity, LLC, being in a position of

  1. 10 percent owner at Soleno Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 2126242 shares for $100.91M,
    over all time since 2024-04-29, has bought 0 shares, and sold 2126242 shares for $100.91M.

The largest purchase of all time was on 2022-12-23 and amounted to 758620 shares of Terns Pharmaceuticals, Inc. for $5.5M.

The largest sale of all time was on 2024-04-29 and amounted to 750000 shares of Soleno Therapeutics, Inc. for $35.85M.

Biography of Vivo Opportunity, LLC

No biography is available at this moment.

2024-08-29SaleSoleno Therapeutics, Inc.
SLNO
10 percent owner
100,000
0.2609%
$47.22$4.72M+10.82%
2024-08-28SaleSoleno Therapeutics, Inc.
SLNO
10 percent owner
425,000
1.101%
$47.35$20.12M+9.2%
2024-08-27SaleSoleno Therapeutics, Inc.
SLNO
10 percent owner
500,000
1.2782%
$48.73$24.36M+4.16%
2024-04-30SaleSoleno Therapeutics, Inc.
SLNO
10 percent owner
351,242
1.0623%
$45.13$15.85M+5.37%
2024-04-29SaleSoleno Therapeutics, Inc.
SLNO
10 percent owner
750,000
2.3567%
$47.80$35.85M+3.32%
2024-04-03SaleTerns Pharmaceuticals, Inc.
TERN
10 percent owner
138,066
0.2207%
$6.20$856,009+20.38%
2024-04-02SaleTerns Pharmaceuticals, Inc.
TERN
10 percent owner
101,480
0.1572%
$6.65$674,842+8.89%
2024-04-01SaleTerns Pharmaceuticals, Inc.
TERN
10 percent owner
181,117
0.2758%
$6.99$1.27M+1.83%
2022-12-23PurchaseTerns Pharmaceuticals, Inc.
TERN
director
758,620
1.2188%
$7.25$5.5M+0.36%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.